CClinicalTrials.gg
CompletedNCT02610907Updated Jan 20, 2016

A Pilot Evaluation of Adhesives and How They Are Impacted by Out-put

An interventional study of Buffer and Own output in Ileostomy, sponsored by Coloplast A/S. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-01-20.

Sponsored by Coloplast A/S · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The study investigates the impact real output (subjects own) and simulated output have on the adhesion of adhesives.

02

Conditions studied

  • Ileostomy
03

In context

Lead sponsor

Coloplast A/S is the lead sponsor of 146 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Have given written informed consent
  2. Be at least 18 years of age and have full legal capacity
  3. Have had an ileostomy for more than one year
  4. Have intact skin on the area used in the evaluation
  5. Has an ileostomy with a diameter up to (≤) 35 mm
  6. Have a peristomal area accessible for application of patches/adhesive strips (assessed by investigating scientist)

Exclusion criteria

Exclusion Criteria:

  1. Currently receiving or have within the past 2 month received radio- and/or chemotherapy
  2. Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
  3. Are pregnant or breastfeeding
  4. Having dermatological problems in the peristomal- or abdominal area (assessed by investigating scientist)
  5. Participating in other interventional clinical investigations or have previously participated in this evaluation
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
4 participants (actual)

Study arms

  • Experimental
    Cohort 01a

    This is a sub-study testing three patches consisting of an adhesive patch and a sleeve. The sleeve can contain one of three solutions: Buffer Own output Simulated output (digestive enzymes) All subjects will test the three solutions at the same time, hence the three patches with different solutions will be placed on the peristomal skin simultanously.

    Other: Buffer · Other: Own output · Other: simulated output

Interventions

  • OtherBuffer

    The sleeve contains phosphate buffered saline buffer

  • OtherOwn output

    The sleeve contains the subject own ileal effluent

  • Othersimulated output

    The sleeve contains simulated output

06

What researchers measure

Primary outcomes

  1. Remaining adhesive area of adhesive

    The remaining adherent area of the adhesive is assessed by subtracting the area of output and swelling from the total adhesive area.

    Time frame: 30 hours

07

Study locations

1 site
  • Coloplast A/S
    Humlebaek, 3050, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 20, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02610907
Lead sponsor
Coloplast A/S
Responsible party
Sponsor
First posted
Nov 20, 2015
Start date
Nov 2015
Primary completion
Jan 2016
Completion
Jan 2016
Last update
Jan 20, 2016

Study contacts

Lene F Nielsen, MSc
principal investigator · R&D Principal Scientist

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion